International LDL Thresholds

Panelists discuss how international guidelines—particularly European ones—have adopted aggressive low-density lipoprotein (LDL) thresholds below 55 mg/dL for high-risk patients. These approaches have driven measurable improvements in cardiovascular outcomes abroad.

The conversation examines whether the US should follow suit, balancing clinical benefit against cost, feasibility, and patient adherence.

Panelists agree that while uniform LDL standards could reduce confusion, US implementation would require payer alignment and system-wide commitment.